AGI-14100

CAT: 0804-HY-120181-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-120181-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
AGI-14100 is a metabolically stable and orally available mIDH1 inhibitor (IC50=6 nM) . The pharmacochemical optimization of AGI-14100 is aimed at eliminating hPXR activation, resulting in the final drug candidate AG-120. AG-120 can be used in the study of cancers carrying IDH1 mutations. The discovery and development of AGI-14100 can be used for further studies of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitors[1].
CAS Number
[1448346-43-7]
UNSPSC
12352005
Target
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/agi-14100.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](N1C2=NC=CC(C#N)=C2)CCC1=O)N([C@@H](C3=CC=CC=C3Cl)C(NC4CC(C4)(F)F)=O)C5=CC(F)=CC(F)=C5
Molecular Formula
C29H22ClF4N5O3
Molecular Weight
599.96
References & Citations
[1]Popovici-Muller J, et al. Discovery of AG-120 (Ivosidenib) : a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers[J]. ACS medicinal chemistry letters, 2018, 9 (4) : 300-305.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-156996AGI-134
HY-112129-01AGI-25696
HY-18082-01AGI-5198
HY-121736-01AGI-12026
HY-145778-01AGI-41998
HY-145777-01AGI-43192
HY-112130-01AGI-24512
HY-15734-01AGI-6780
HY-123665-01PSB-1410

Alternative Products

CatalogName
M34048-01AGI-14100
sc-480257AGI-6780
MBS3601453-01AGI-5198
7087/25AGI 5198
MBS5825367AGI-43192
MBS5825368AGI-41998
MBS5776303AGI-026
MBS5766007AGI-25696
E1806-100mgAGI-24512

Popular Products